Plain-AuNPs oral and SAF groups significantly decreased Wnt-3a level in the liver by 19.06% (p < 0.001) and 49.86% (P < 0.001), respectively, than HCC group. This evidence concerns the gene WNT3A and hepatocellular carcinoma.